How should primary hypothyroidism be confirmed and initially treated, including levothyroxine dosing for a healthy adult, dose reductions for elderly or coronary artery disease patients, and dose increase during pregnancy?

Primary Hypothyroidism: Confirmation, Treatment, and Dosing

Diagnostic Confirmation

Confirm primary hypothyroidism by measuring both TSH and free T4, with TSH >10 mIU/L or any TSH elevation with low free T4 indicating need for treatment. 1

• Repeat TSH and free T4 after 3-6 weeks before initiating therapy, as 30-60% of elevated TSH values normalize spontaneously 1, 2
• Measure anti-TPO antibodies to identify autoimmune etiology (Hashimoto's thyroiditis), which predicts 4.3% annual progression risk versus 2.6% in antibody-negative patients 1
• TSH has 98% sensitivity and 92% specificity for detecting thyroid dysfunction 1

Exclude Transient Causes Before Treatment

• Rule out recent acute illness, hospitalization, or recovery from thyroiditis—all can transiently elevate TSH 1
• Check for recent iodine exposure (CT contrast), medications (lithium, amiodarone), or assay interference 1
• Critical: In suspected central hypothyroidism or patients on immunotherapy, measure morning cortisol and ACTH before starting levothyroxine, as thyroid hormone can precipitate life-threatening adrenal crisis 1, 3

---

Initial Levothyroxine Dosing for Healthy Adults

For healthy adults under 70 years without cardiac disease, start levothyroxine at full replacement dose of 1.6 mcg/kg/day based on ideal body weight. 1, 3

• This approach rapidly normalizes thyroid function and prevents cardiovascular dysfunction, adverse lipid profiles, and quality of life deterioration 1
• Monitor TSH and free T4 every 6-8 weeks during dose titration until TSH reaches target range of 0.5-4.5 mIU/L 1, 2
• Adjust dose by 12.5-25 mcg increments based on TSH response 1
• Once stable, monitor TSH every 6-12 months 1, 2

Administration Guidelines

• Take levothyroxine on empty stomach, 30-60 minutes before breakfast 1
• Separate from iron, calcium supplements, or antacids by at least 4 hours 1

---

Dose Reductions for Elderly and Cardiac Patients

For patients over 70 years OR those with coronary artery disease, start at 25-50 mcg/day and titrate slowly by 12.5-25 mcg every 6-8 weeks. 1, 3, 4

Rationale for Conservative Dosing

• Rapid normalization can unmask or worsen cardiac ischemia, precipitate myocardial infarction, heart failure, or fatal arrhythmias 1, 4
• Elderly patients with coronary disease are at highest risk of cardiac decompensation even with therapeutic levothyroxine doses 1
• Starting at full replacement dose in these populations carries unacceptable cardiovascular risk 1

Monitoring in High-Risk Patients

• Obtain baseline ECG to screen for arrhythmias, especially atrial fibrillation 1
• Assess for new or worsening angina, palpitations, dyspnea at each follow-up 1
• For patients with atrial fibrillation or serious cardiac conditions, consider repeating TSH within 2 weeks rather than waiting 6-8 weeks 1
• Target TSH 0.5-4.5 mIU/L, though slightly higher targets (up to 5-6 mIU/L) may be acceptable in very elderly patients to avoid overtreatment risks 1

---

Pregnancy Dosing Adjustments

Women with pre-existing hypothyroidism should increase levothyroxine dose by 25-50% immediately upon pregnancy confirmation. 1

Pregnancy-Specific Management

• Target TSH <2.5 mIU/L in first trimester to prevent adverse pregnancy outcomes 1, 5
• Untreated or inadequately treated maternal hypothyroidism increases risk of preeclampsia, low birth weight, miscarriage, and permanent neurodevelopmental deficits in offspring 1, 5
• Check TSH and free T4 every 4 weeks until stable, then at minimum once per trimester 1
• Adjust dose by 12.5-25 mcg increments based on TSH results 1
• Use levothyroxine monotherapy only—T3 supplementation provides inadequate fetal thyroid hormone delivery 1

Women Planning Pregnancy

• Treat any TSH elevation before conception, not during pregnancy 1
• TSH >2.5 mIU/L increases spontaneous abortion risk 3.7-fold compared to TSH 0.1-2.5 mIU/L 5
• TSH >4.6 mIU/L increases spontaneous abortion risk 5.9-fold 5
• Levothyroxine treatment reduces miscarriage rate from 28.6% to 9.8% in women with elevated TSH 5

---

Critical Safety Considerations

Adrenal Insufficiency Screening

Always rule out adrenal insufficiency before starting levothyroxine in patients with autoimmune hypothyroidism, central hypothyroidism, or unexplained hypotension/hyponatremia. 1, 3

• Measure morning (8 AM) cortisol and ACTH 1
• If adrenal insufficiency confirmed, start hydrocortisone 20 mg morning/10 mg afternoon for at least one week before levothyroxine 1
• In central hypothyroidism or hypophysitis, always replace cortisol before thyroxine to prevent adrenal crisis 1, 3

Overtreatment Risks

• Approximately 25% of patients on levothyroxine are unintentionally maintained with suppressed TSH, increasing serious complication risks 1
• TSH <0.1 mIU/L increases atrial fibrillation risk 3-5 fold, especially in patients over 60 1
• Prolonged TSH suppression causes osteoporosis, fractures (particularly in postmenopausal women), and increased cardiovascular mortality 1
• If TSH <0.1 mIU/L, reduce dose by 25-50 mcg immediately 1
• If TSH 0.1-0.45 mIU/L, reduce by 12.5-25 mcg, particularly in elderly or cardiac patients 1

---

Common Pitfalls to Avoid

• Never treat based on single elevated TSH—confirm with repeat testing 1, 2
• Never start thyroid hormone before ruling out adrenal insufficiency in suspected central hypothyroidism 1, 3
• Never use full replacement dose in elderly or cardiac patients—start low and go slow 1, 4
• Avoid adjusting doses more frequently than every 6-8 weeks before steady state is reached 1
• Do not ignore suppressed TSH in elderly patients—this directly causes fractures and atrial fibrillation 1
• Recognize that 12% of persons aged 80+ with no thyroid disease have TSH >4.5 mIU/L, making age-adjusted reference ranges important 6, 1